A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

MezagitamabOngoingRecruitingPhase 3Open NCT06948318 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…